Back to Search Start Over

Mortality in patients with high risk Staphylococcus aureus bacteremia undergoing or not PET-CT: A single center experience

Authors :
Phillippe D'Abadie
Gregory Reychler
Halil Yildiz
Etienne Danse
Laura Orioli
Jean Cyr Yombi
Bernard Vandercam
Hector Rodriguez-Villalobos
Agnes Pasquet
Bernard Vandeleene
UCL - SSS/IREC/PNEU - Pôle de Pneumologie, ORL et Dermatologie
UCL - SSS/IREC/MBLG - Pôle de Microbiologie médicale
UCL - SSS/IREC/EDIN - Pôle d'endocrinologie, diabète et nutrition
UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie
UCL - SSS/IREC/IMAG - Pôle d'imagerie médicale
UCL - SSS/IREC/CARD - Pôle de recherche cardiovasculaire
UCL - SSS/IREC/SLUC - Pôle St.-Luc
UCL - (SLuc) Service de médecine interne générale
UCL - (SLuc) Service de pneumologie
UCL - (SLuc) Service de microbiologie
UCL - (SLuc) Service d'endocrinologie et de nutrition
UCL - (SLuc) Service de médecine nucléaire
UCL - (SLuc) Service de radiologie
UCL - (SLuc) Service de pathologie cardiovasculaire
Source :
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, Vol. 25, no.11, p. 880-885 (2019)
Publication Year :
2019

Abstract

Background Staphylococcus aureus bacteremia (SAB) is associated with significant morbidity and mortality. Previous studies had shown that PET/CT can be helpfull in the management of SAB, leading to reduction of mortality. Factors associated with increased or reduced mortality are not well known. Our objective was to analyze mortality in high risk SAB patients undergoing PET/CT and to identify factors associated with mortality rate. Materials and methods We performed a retrospective study and reviewed all cases of high risk adult SAB between 2014 and 2017. We analyzed medical records and mortality at 30 days and 90 days and 1 year. Results A total of 102 patients were included in whom 48 undergone PET/CT. Metastatic foci was identified in 45.8% of cases (22/48). The overall mortality rate was 31.4% (32/102). The mortality rate was 16.6% (8/48) and 44.4% (24/54) in patients undergoing or not PET/CT respectively (P = 0.002). There was a signicantly difference in mortality rate at 30 days (P = 0.001), 90 days (P = 0.004) and one at 1 year (P = 0.002) between patients undergoing or not PET/CT respectively. In multivariate analysis only 18-FDGPET/CT, kidney failure and bacteremia of unknown origin were the 3 mains factors modifying mortality in patients with high risk SAB. Conclusion In our study mortality rate was reduced in high risk SAB patients undergoing PET/CT. kidney failure and bacteremia of unknown origin were other factors associtated with high mortality. Our study confirm that PET/CT is a usefull tool in the management of SAB.

Details

ISSN :
14377780
Volume :
25
Issue :
11
Database :
OpenAIRE
Journal :
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy
Accession number :
edsair.doi.dedup.....bf973d2eabe0c908ec1788024f47795e